2009 conference paper

Toward a molecular equivalent dose: Use of the medaka model in comparative risk assessment

Comparative Biochemistry and Physiology. C, Toxicology & Pharmacology, 149(2), 141–151.

By: K. Hobbie, A. DeAngelo, L. King, R. Winn & M. Law

Source: NC State University Libraries
Added: August 6, 2018